Find your next paid study

University of California, San FranciscoNCT07561827

~$50 – $1,350

Actual pay is set by the research site.

Phase 2

IIT2022-05-Sankar-BELIEVE: Phase II Study of Bevacizumab in Combination With Chemoimmunotherapy and Maintenance Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases

This clinical trial aims to assess whether the addition of bevacizumab to atezolizumab and chemotherapy can improve response to treatment and progression-free …

Extensive-stage Small-cell Lung CancerLiver Metastases

~$75 – $3,000

Actual pay is set by the research site.

Kamya SankarNCT05588388

Alzheimer DiseaseDementia

Transitional Care for Skilled Nursing Facility Patients With Alzheimer's Disease and Related Dementias and Their Caregivers: a Cluster Randomized Trial

This study is a parallel arm, cluster randomized trial (CRT) to test the efficacy of Connect-Home ADRD, a transitional care intervention focusing on Skilled Nu…

University of North Carolina, Chapel HillNCT06840587

Actual pay is set by the research site.

Malignant Brain TumorGliomaCoping Skills

NeuroPathways: An Information and Support Intervention for Patients With Malignant Brain Tumors

This goal of this study is to test an information and support intervention for patients with malignant (or "high-grade") brain tumors. This study was developed…

Massachusetts General HospitalNCT05976490

Actual pay is set by the research site.

Prospective, Randomized Clinical Trial for Immediate Lymphatic Reconstruction to Prevent Breast Cancer Related Lymphedema

The goal of this clinical trial is to evaluate the effectiveness of Immediate Lymphatic Reconstruction (ILR) in preventing breast cancer-related lymphedema (BC…

Breast Cancer Lymphedema

University of South FloridaNCT07127003

Actual pay is set by the research site.

Phase 1

A Phase 1, Randomized, Placebo-Controlled, First-in-Human, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Orally Administered KT-579 in Healthy Adult Participants

This is a first-in-human study to evaluate safety and tolerability, pharmacokinetics, and pharmacodynamics of single and multiple dose levels of KT-579 in heal…

Healthy Participants

Kymera Therapeutics, Inc.NCT07412288

~$500 – $10,500

Actual pay is set by the research site.

Phase 2

A Phase II Study of Pemigatinib Plus Durvalumab (MEDI4736) in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement

This is a single arm phase II study of pemigatinib and durvalumab combination in patients with FGFR-2 fusion or rearrangement positive intrahepatic cholangioca…

Intrahepatic CholangiocarcinomaFGFR2 Gene RearrangementFGFR2 Gene Mutation

~$75 – $3,000

Actual pay is set by the research site.

Mehmet AkceNCT06728410

Pacemaker ImplantationAV Node Disease

Efficacy and Safety of Leadless Pacemakers Versus Left Bundle Area Pacing - A Preliminary Exploration

This is a prospective, randomized controlled (1:1) multicenter trial. The pilot study will be conducted up to three clinical sites in the United States. The pr…

NCH Healthcare System, Inc. dba Naples Comprehensive Health and dba NCHNCT06690333

~$10 – $1,050

Actual pay is set by the research site.

Phase 2

A 12-Week Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Assess the Efficacy of Oral Fosamprenavir for Laryngopharyngeal Reflux

Laryngopharyngeal Reflux (LPR) is a common condition that causes symptoms like chronic cough, throat clearing, hoarseness, and trouble swallowing. If not treat…

Laryngopharyngeal Reflux

Medical College of WisconsinNCT04383262

~$75 – $2,000

Actual pay is set by the research site.

A Multi-Modal Wearable Sensor for Early Detection of Cognitive Decline and Remote Monitoring of Cognitive-Motor Decline Over Time

This observational study will enroll approximately 100 participants evenly split by cognitive status (Cognitively Impaired vs Non-Cognitively Impaired), and in…

Mild Cognitive Impairment (MCI)Older Adults With Cognitive DeclineOlder Adults

LymphomaNon-Hodgkin LymphomaHodgkin Lymphoma+4 more

~$10 – $1,125

Actual pay is set by the research site.

BioSensicsNCT07780162

Phase 1

A Modular Phase I/II, Open-label, Multicentre Study to Evaluate the Safety, Tolerability, and Efficacy of AZD3470, a PRMT5 Inhibitor, as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies

This study is designed to evaluate the safety, tolerability, PK, pharmacodynamics, and preliminary efficacy following oral administration of AZD3470 as a monot…

~$150 – $4,500

Actual pay is set by the research site.

AstraZenecaNCT06137144

Cerebral Palsy ChildrenMotor DisabilitiesDevelopmental Disability+3 more

Bridging the Gap: Implementing A Powered Mobility Intervention Into Early Childhood Settings for Young Children With Cerebral Palsy (GMFCS IV-V)

The goal of this clinical trial is to learn if a therapist training program can help providers in Part C Early Childhood Settings use powered mobility (PM) wit…